Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion

Cancer Genetics and Cytogenetics

Volumn 172, Issue 2, 2007, Pages 120-126

  Joshi, Avadhut D ^a   Dickinson, John D ^a   Hegde, Ganapati V ^a   Sanger, Warren G ^a   Armitage, James O ^a   Bierman, Philip J ^a   Bociek, Robert G ^a   Devetten, Marcel P ^a   Vose, Julie M ^a   Joshi, Shantaram S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; APOPTOSIS; ARTICLE; ATM GENE; B CELL LEUKEMIA; BULKY LYMPHADENOPATHY; CELL ADHESION; CELL CYCLE; CELL CYCLE REGULATION; CHROMOSOME 11Q; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

CELL ADHESION; CELL CYCLE; CELL CYCLE PROTEINS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 33845929201     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.07.010     Document Type: Article

References (32)

1. Chiorazzi N., Rai K.R., and Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 352 (2005) 804-815
2. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., and Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood 46 (1975) 219-234
3. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M.T., Monconduit M., Belabbes S., and Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48 (1981) 198-206
4. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., Buchbinder A., Budman D., Dittmar K., Kolitz J., Lichtman S.M., Schulman P., Vinciguerra V.P., Rai K.R., Ferrarini M., and Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94 (1999) 1840-1847
5. Dohner H., Stilgenbauer S., Dohner K., Bentz M., and Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 77 (1999) 266-281
6. Schaffner C., Stilgenbauer S., Rappold G.A., Dohner H., and Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 94 (1999) 748-753
7. Boultwood J. Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol 54 (2001) 512-516
8. Watters D., Khanna K.K., Beamish H., Birrell G., Spring K., Kedar P., Gatei M., Stenzel D., Hobson K., Kozlov S., Zhang N., Farrell A., Ramsay J., Gatti R., and Lavin M. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 14 (1997) 1911-1921
9. Zakian V.A. ATM-related genes: what do they tell us about functions of the human gene?. Cell 82 (1995) 685-687
10. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., and Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281 (1998) 1677-1679
11. Banin S., Moyal L., Shieh S., Taya Y., Anderson C.W., Chessa L., Smorodinsky N.I., Prives C., Reiss Y., Shiloh Y., and Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281 (1998) 1674-1677
12. Taylor A.M., Metcalfe J.A., Thick J., and Mak Y.F. Leukemia and lymphoma in ataxia telangiectasia. Blood 87 (1996) 423-438
13. Dickinson J.D., Gilmore J., Iqbal J., Sanger W., Lynch J.C., Chan J., Bierman P.J., and Joshi S.S. 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules. Leuk Lymphoma 47 (2006) 231-244
14. Dohner H., Stilgenbauer S., James M.R., Benner A., Weilguni T., Bentz M., Fischer K., Hunstein W., and Lichter P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89 (1997) 2516-2522
15. Dickinson J.D., Smith L.M., Sanger W.G., Zhou G., Townley P., Lynch J.C., Pavletic Z.S., Bierman P.J., and Joshi S.S. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia. Br J Haematol 128 (2005) 460-471
16. Wang P., Munger C.M., Joshi A.D., Pirruccello S.J., and Joshi S.S. Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo. Breast Cancer Res Treat 83 (2004) 15-23
17. Dickinson J.D., Joshi A., Iqbal J., Sanger W., Bierman P.J., and Joshi S.S. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect. Int J Mol Med 17 (2006) 769-778
18. Faderl S., Keating M.J., Do K.A., Liang S.Y., Kantarjian H.M., O'Brien S., Garcia-Manero G., Manshouri T., and Albitar M. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL). Leukemia 16 (2002) 1045-1052
19. Austen B., Powell J.E., Alvi A., Edwards I., Hooper L., Starczynski J., Taylor A.M., Fegan C., Moss P., and Stankovic T. Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL. Blood 106 (2005) 3175-3182
20. Whiteside D., McLeod R., Graham G., Steckley J.L., Booth K., Somerville M.J., and Andrew S.E. A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple cafe-au-lait spots. Cancer Res 62 (2002) 359-362
21. Hickman M.J., and Samson L.D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci U S A 96 (1999) 10764-10769
22. Wu J., Gu L., Wang H., Geacintov N.E., and Li G.M. Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis. Mol Cell Biol 19 (1999) 8292-8301
23. Larson E.D., Cummings W.J., Bednarski D.W., and Maizels N. MRE11/RAD50 cleaves DNA in the AID/UNG-dependent pathway of immunoglobulin gene diversification. Mol Cell 20 (2005) 367-375
24. Lopez-Giral S., Quintana N.E., Cabrerizo M., Alfonso-Perez M., Sala-Valdes M., De Soria V.G., Fernandez-Ranada J.M., Fernandez-Ruiz E., and Munoz C. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol 76 (2004) 462-471
25. Till K.J., Lin K., Zuzel M., and Cawley J.C. The chemokine receptor CCR7 and α4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood 99 (2002) 2977-2984
26. Stratowa C., Loffler G., Lichter P., Stilgenbauer S., Haberl P., Schweifer N., Dohner H., and Wilgenbus K.K. cDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 91 (2001) 474-480
27. Angelopoulou M.K., Kontopidou F.N., and Pangalis G.A. Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol 36 (1999) 178-197
28. Perk J., Iavarone A., and Benezra R. Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5 (2005) 603-614 [Erratum in: Nat Rev Cancer 2005;5:750]
29. Fong S., Debs R.J., and Desprez P.Y. Id genes and proteins as promising targets in cancer therapy. Trends Mol Med 10 (2004) 387-392
30. Schoppmann S.F., Schindl M., Bayer G., Aumayr K., Dienes J., Horvat R., Rudas M., Gnant M., Jakesz R., and Birner P. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer 104 (2003) 677-682
31. Santagata S., Demichelis F., Riva A., Varambally S., Hofer M.D., Kutok J.L., Kim R., Tang J., Montie J.E., Chinnaiyan A.M., Rubin M.A., and Aster J.C. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 64 (2004) 6854-6857
32. Veeraraghavalu K., Subbaiah V.K., Srivastava S., Chakrabarti O., Syal R., and Krishna S. Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation. J Virol 79 (2005) 7889-7898